CAS 439575-02-7

N-(5-((5-(4-Acetylpiperazine-1-carbonyl)-4-methoxy-2-methylphenyl)thio)thiazol-2-yl)-4-(((3,3-dimethylbutan-2-yl)amino)methyl)benzamide

CAS : 439575-02-7

Formule : C₃₂H₄₁N₅O₄S₂

Degré de pureté : %

Masse moléculaire : 623.8290

Ref: IN-DA003AJJ

BMS 509744

CAS : 439575-02-7

BMS 509744 is a tyrosine kinase inhibitor. It inhibits the activation of the signal pathways that are involved in the proliferation of t-cells. BMS 509744 has been shown to be effective in inhibiting cancer cells, with a particular focus on T-cell lymphomas. The drug also inhibits inflammation by inhibiting toll-like receptor. This drug has been shown to have an effective dose of 10mg in animal studies and is currently undergoing clinical trials for use against inflammatory diseases, such as rheumatoid arthritis and psoriasis.

Formule : C₃₂H₄₁N₅O₄S₂

Degré de pureté : Min. 95%

Masse moléculaire : 623.83 g/mol

Ref: 3D-PSA57502

BMS-509744

CAS : 439575-02-7

BMS-509744 is an inhibitor of ATP competitive Itk (IC50: 19 nM).

Formule : C₃₂H₄₁N₅O₄S₂

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 623.83

Ref: TM-T14674